Trough Level Targeting
Trough Level Targeting is a pharmacokinetic strategy within mTOR inhibitor therapy that involves adjusting drug dosages to maintain plasma concentrations at a predetermined minimum level immediately before the next administration, thereby optimizing therapeutic efficacy while minimizing toxicity.
16
Publications
1.2K
Citations
111
Authors
48
Institutions
Publications per year
2017–2026
6
Variants
Trough-level-guided Dosing
Parents
16
1–5 of 16
111
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 111
48
Rutgers, The State University of New Jersey
New Brunswick, United States
2 h-index
2 publications
26 citations
Tokyo University of Pharmacy and Life Sciences
Hachiōji, Japan
2 h-index
5 publications
82 citations
Tokyo Medical University Hachioji Medical Center
Tokyo, Japan
2 h-index
20 publications
383 citations

Medical University of Lublin
Lublin, Poland
2 h-index
2 publications
26 citations

Sheba Medical Center
Ramat Gan, Israel
1 h-index
9 publications
126 citations

Tel Aviv University
Tel Aviv, Israel
1 h-index
9 publications
126 citations

Vancouver General Hospital
Vancouver, Canada
1 h-index
2 publications
44 citations
UCLouvain
Louvain-la-Neuve, Belgium
1 h-index
1 publications
48 citations
1–8 of 48
3 publications · 113 citations
3
h-index
2 publications · 35 citations
2
h-index
1 publications · 57 citations
1
h-index
1 publications · 14 citations
1
h-index
1 publications · 15 citations
1
h-index
1–5